Yusa K - Search Results

1

Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.

Davis DA, Yusa K, Gillim LA, Newcomb FM, Mitsuya H, Yarchoan R. Davis DA, et al. Among authors: yusa k. J Virol. 1999 Feb;73(2):1156-64. doi: 10.1128/JVI.73.2.1156-1164.1999. J Virol. 1999. PMID: 9882317 Free PMC article.

2

HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination.

Yusa K, Kavlick MF, Kosalaraksa P, Mitsuya H. Yusa K, et al. Antiviral Res. 1997 Dec;36(3):179-89. doi: 10.1016/s0166-3542(97)00053-3. Antiviral Res. 1997. PMID: 9477118

3

JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

Yoshimura K, Kato R, Yusa K, Kavlick MF, Maroun V, Nguyen A, Mimoto T, Ueno T, Shintani M, Falloon J, Masur H, Hayashi H, Erickson J, Mitsuya H. Yoshimura K, et al. Among authors: yusa k. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8675-80. doi: 10.1073/pnas.96.15.8675. Proc Natl Acad Sci U S A. 1999. PMID: 10411934 Free PMC article.

4

Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.

Kodama EN, McCaffrey RP, Yusa K, Mitsuya H. Kodama EN, et al. Among authors: yusa k. Biochem Pharmacol. 2000 Feb 1;59(3):273-81. doi: 10.1016/s0006-2952(99)00325-1. Biochem Pharmacol. 2000. PMID: 10609556

5

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.

Yusa K, Oh-hara T, Tsukahara S, Baba K, Taniguchi M, Kozawa M, Takeuchi S, Hara H, Tsuruo T. Yusa K, et al. Antiviral Res. 1994 Sep;25(1):57-66. doi: 10.1016/0166-3542(94)90093-0. Antiviral Res. 1994. PMID: 7529015

6

Comparison of glutathione S-transferase activity between drug-resistant and -sensitive human tumor cells: is glutathione S-transferase associated with multidrug resistance?

Yusa K, Hamada H, Tsuruo T. Yusa K, et al. Cancer Chemother Pharmacol. 1988;22(1):17-20. doi: 10.1007/BF00254174. Cancer Chemother Pharmacol. 1988. PMID: 3396143

7

Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells.

Yusa K, Oh-hara T, Yamazaki A, Tsukahara S, Satoh W, Tsuruo T. Yusa K, et al. Biochem Biophys Res Commun. 1990 Jun 29;169(3):986-90. doi: 10.1016/0006-291x(90)91991-z. Biochem Biophys Res Commun. 1990. PMID: 2163639

8

Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.

Yusa K, Oh-hara T, Tsuruo T. Yusa K, et al. Biochem Biophys Res Commun. 1995 Jan 17;206(2):486-91. doi: 10.1006/bbrc.1995.1069. Biochem Biophys Res Commun. 1995. PMID: 7826366

9

Interhomolog recombination and loss of heterozygosity in wild-type and Bloom syndrome helicase (BLM)-deficient mammalian cells.

LaRocque JR, Stark JM, Oh J, Bojilova E, Yusa K, Horie K, Takeda J, Jasin M. LaRocque JR, et al. Among authors: yusa k. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11971-6. doi: 10.1073/pnas.1104421108. Epub 2011 Jul 5. Proc Natl Acad Sci U S A. 2011. PMID: 21730139 Free PMC article.

10

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.

Pettitt SJ, Krastev DB, Brandsma I, Dréan A, Song F, Aleksandrov R, Harrell MI, Menon M, Brough R, Campbell J, Frankum J, Ranes M, Pemberton HN, Rafiq R, Fenwick K, Swain A, Guettler S, Lee JM, Swisher EM, Stoynov S, Yusa K, Ashworth A, Lord CJ. Pettitt SJ, et al. Among authors: yusa k. Nat Commun. 2018 May 10;9(1):1849. doi: 10.1038/s41467-018-03917-2. Nat Commun. 2018. PMID: 29748565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters